Skip to main content
. 2022 Apr 5;27(5):522–536. doi: 10.1111/tmi.13748

TABLE 2.

Respondents' perceived access to and utilisation of COVID‐19 testing

Rural (Banten, North Sulawesi) Urban (Jakarta) Sub‐total (Rural and urban) Total (N = 630)
Banten (13,504 confirmed cases) a North Sulawesi (5965 confirmed cases) a Jakarta (29,633 confirmed cases) a Rural & Urban
Female (n = 106) Male (n = 104) Female (n = 109) Male (n = 101) Female (n = 103) Male (n = 107) Female (n = 318) Male (n = 312)
Feeling at risk
No risk 10 (9.43) 13 (12.50) 7 (6.42) 2 (1.98) 7 (6.80) 9 (8.41) 24 (7.55) 24 (7.69) 48 (7.62)
Low risk 46 (43.40) 31 (29.81) 24 (22.02) 20 (19.80) 14 (13.59) 10 (9.35) 84 (26.42) 61 (19.55) 145 (23.02)
Mild risk 28 (26.42) 36 (34.62) 51 (46.79) 54 (53.47) 29 (28.16) 28 (26.17) 108 (33.96) 118 (37.82) 226 (35.87)
Moderate risk 17 (16.04) 17 (16.35) 12 (11.01) 14 (13.86) 21 (20.39) 20 (18.69) 50 (15.72) 51 (16.35) 101 (16.03)
High risk 5 (4.72) 7 (6.73) 15 (13.76) 11 (10.89) 32 (31.07) 40 (37.38) 52 (16.35) 58 (18.59) 110 (17.46)
Household members
Children only 13 (12.26) 10 (9.62) 14 (12.84) 9 (8.91) 2 (1.90) 1 (0.90) 29 (9.12) 20 (6.41) 49 (7.78)
Children and elders 13 (12.26) 2 (1.92) 0 (0.00) 4 (3.96) 0 (0.00) 0 (0.00) 13 (4.09) 6 (1.92) 19 (3.02)
Children, elders and chronic disease (CD) 5 (4.72) 5 (4.81) 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 5 (1.57) 5 (1.60) 10 (1.59)
Elders only 14 (13.21) 11 (10.58) 17 (15.60) 13 (12.87) 8 (7.80) 6 (5.60) 39 (12.26) 30 (9.62) 69 (10.95)
Elders and CD 20 (18.87) 11 (10.58) 2 (1.83) 1 (0.99) 0 (0.00) 1 (0.90) 22 (6.92) 13 (4.17) 35 (5.56)
CD only 2 (1.89) 4 (3.85) 4 (3.67) 6 (5.94) 4 (3.90) 2 (1.90) 10 (3.14) 12 (3.85) 22 (3.49)
Children and CD 0 (0.00) 0 (0.00) 1 (0.92) 0 (0.00) 0 (0.00) 0 (0.00) 1 (0.31) 0 (0.00) 1 (0.16)
Previously had COVID‐19
Yes, confirmed by test 3 (2.83) 2 (1.92) 2 (1.83) 0 (0.00) 4 (3.88) 9 (8.41) 9 (2.83) 11 (3.53) 20 (3.17)
Yes, confirmed by a healthcare worker 0 (0.00) 1 (0.96) 0 (0.00) 0 (0.00) 6 (5.83) 7 (6.54) 6 (1.89) 8 (2.56) 14 (2.22)
Feeling they cannot access testing when needed
Never 102 (96.23) 100 (96.15) 105 (96.33) 90 (89.11) 97 (94.17) 103 (96.26) 304 (95.60) 293 (93.91) 597 (94.76)
At least once 3 (3.77) 3 (3.84) 4 (3.64) 9 (10.99) 6 (5.83) 4 (3.74) 13 (4.09) 16 (5.13) 29 (4.60)
Previously tested for COVID‐19
Never 76 (71.70) 64 (61.54) 88 (80.73) 78 (77.23) 54 (52.43) 49 (45.79) 218 (68.55) 191 (61.22) 409 (64.92)
At least once 30 (28.30) 40 (38.46) 21 (19.27) 23 (22.77) 49 (47.57) 58 (54.21) 99 (31.13) 121 (38.78) 220 (34.92)
For the respondents who had ever tested for COVID‐19 (n=) 29 40 21 23 49 58 99 121 220
Months ago (mean, SD) 3.241 (0.87) 3.19 (0.92) 3.19 (0.87) 3.30 (0.86) 3.1 (3.57) 3.1 (3.37) 2.8 (3.21) 2.5 (2.78) 2.6 (2.98)
Very convenient 0 (0.00) 0 (0.00) 0 (0.00) 0 (0.00) 1 (2.04) 2 (3.45) 1 (1.01) 2 (1.65) 3 (1.36)
Convenient 15 (51.72) 25 (62.50) 10 (47.62) 13 (56.52) 11 (22.45) 26 (44.83) 36 (36.36) 64 (52.89) 100 (45.45)
Neutral 6 (20.69) 5 (12.50) 5 (23.81) 4 (17.39) 7 (14.29) 17 (29.31) 18 (18.18) 26 (21.49) 44 (20.00)
Inconvenient 8 (27.59) 9 (22.50) 6 (28.57) 6 (26.09) 26 (53.06) 11 (18.97) 40 (40.40) 26 (21.49) 66 (30.00)
Very inconvenient 0 (0.00) 1 (2.50) 0 (0.00) 0 (0.00) 4 (8.16) 2 (3.45) 4 (4.04) 3 (2.48) 7 (3.18)
Result in less than 1 h 5 (17.24) 11 (27.50) 13 (61.90) 15 (65.22) 8 (16.33) 12 (20.69) 26 (26.26) 38 (31.40) 64 (29.09)
Result the same day 20 (68.97) 21 (52.50) 2 (9.52) 5 (21.74) 27 (55.10) 25 (43.10) 49 (49.49) 51 (42.15) 100 (45.45)
The following day 1 (3.45) 1 (2.50) 1 (4.76) 0 (0.00) 7 (14.29) 13 (22.41) 9 (9.09) 14 (11.57) 23 (10.45)
Two days later 0 (0.00) 1 (2.50) 1 (4.76) 0 (0.00) 3 (6.12) 2 (3.45) 4 (4.04) 3 (2.48) 7 (3.18)
3–7 days later 3 (10.34) 3 (7.50) 1 (4.76) 1 (4.35) 4 (8.16) 5 (8.62) 8 (8.08) 9 (7.44) 17 (7.73)
More than 1 week later 0 (0.00) 3 (7.50) 3 (14.29) 0 (0.00) 0 (0.00) 1 (1.72) 3 (3.03) 4 (3.31) 7 (3.18)
Never received the result 0 (0.00) 0 (0.00) 0 (0.00) 2 (8.70) 0 (0.00) 0 (0.00) 0 (0.00) 2 (1.65) 2 (0.91)
Paid for the test 13 (44.83) 17 (42.50) 7 (33.33) 4 (18.18) 29 (59.18) 36 (62.07) 49 (49.49) 57 (47.50) 106 (48.40)
Payment, USD (median, IQR) 12.25 (2.1) 10.5 (1.75) 17.5 (3.5) 15.75 (3.5) 11.2 (3.5) 10.5 (4.55) 12.25 (7) 10.5 (2.1) 10.5 (3.5)
a

Number of confirmed cases during the survey period (31st July–16th August) in the setting, as per [15]. The First ‘–’ is “Perceived convenience of last test”, The Second ‘–’ is “Turnaround time of last test”, and The Third ‘–’ is “Payment done for last lest”.